<DOC>
	<DOCNO>NCT00002037</DOCNO>
	<brief_summary>To examine effectiveness subcutaneous gamma interferon reduce severity Mycobacterium avium- intracellulare ( MAI ) bacillemia episode AIDS patient open-label dose-randomized multi-center pilot clinical investigation . To evaluate safety gamma interferon give subcutaneous injection ( SC ) AIDS patient presence absence AZT therapy .</brief_summary>
	<brief_title>Evaluation Therapeutic Benefit r-metHuIFN- Gamma AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare ( MAI ) Infection : A Multi-Centered Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Mycobacterium Infections</mesh_term>
	<mesh_term>Mycobacterium avium-intracellulare Infection</mesh_term>
	<mesh_term>Trifluridine</mesh_term>
	<criteria>Inclusion Criteria Patients must : Diagnosis AIDS persistent Mycobacterium avium intracellulare ( MAI ) bacillemia . Life expectancy least 3 month . Baseline chest Xray EKG ( electrocardiogram ) . Exclusion Criteria Coexisting Condition : Patients follow condition symptom exclude : Known hypersensitivity interferon exogenous lymphokine . History cardiac abnormality disease . History hypertension . Patients follow excluded : Known hypersensitivity interferon exogenous lymphokine . History cardiac abnormality disease . History hypertension . Prior Medication : Excluded within 4 week study entry : Corticosteroids . Antiinflammatory medication ( except aspirin ) . Changes dose antimycobacterial drug . Immune agent . Prior Treatment : Excluded within 4 week study entry : Radiotherapy . Risk Behavior : Excluded : Intravenous drug abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 1991</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Mycobacterium avium-intracellulare Infection</keyword>
	<keyword>Interferon-gamma , Recombinant</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
</DOC>